title: Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome.
abstract: OBJECTIVE
  To re-evaluate the relation between plasma interleukin-10 (IL-10) concentration at hospital admission and outcome and to investigate the impact of single nucleotide polymorphisms (SNP) in the IL-10 gene in patients with non-ST elevation acute coronary syndrome (ACS).
  
  
  METHODS
  Determination of IL-10 plasma concentrations and genotyping of SNPs in the IL-10 gene in a prospective trial of patients with ACS and in a group of healthy controls.
  
  
  METHODS
  3179 patients in the Fragmin and fast revascularisation during InStability in Coronary artery disease II (FRISC II) trial and 393 healthy controls.
  
  
  METHODS
  Mortality and incidence of myocardial infarction (MI) at 12 months.
  
  
  RESULTS
  The median and interquartile ranges of IL-10 were 0.8 (0.5-1.0) pg/ml in healthy controls and 1.1 (0.7-1.9) pg/ml in patients (p<0.001). In patients, IL-10 predicted a crude risk increase of death/MI, with the highest risk observed in the fourth quartile (adjusted odds ratio 1.7 (95% confidence interval 1.2 to 2.3)). Adjustment for common risk indicators, including C-reactive protein and interleukin-6, weakened the association to a non-significant level. The 1170 CC genotype weakly predicted increased plasma concentrations of IL-10 in patients (p = 0.04) and in controls (p = 0.03), which was consistent with the modest association of this variant with coronary disease (p = 0.01).
  
  
  CONCLUSIONS
  In contrast with some previous reports, we conclude that IL-10 reflects a proinflammatory state in patients with ACS and we therefore suggest that IL-10 is as effective a biomarker for the risk prediction of future cardiovascular events as other markers of systemic inflammation.
authors: Department of Medical Sciences, Clinical Chemistry, Uppsala University, S-751 85 Uppsala, Sweden.
authors: A
authors: A
authors: Mälarstig
authors: P
authors: P
authors: Eriksson
authors: A
authors: A
authors: Hamsten
authors: B
authors: B
authors: Lindahl
authors: L
authors: L
authors: Wallentin
authors: A
authors: A
authors: Siegbahn
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000401:mortality; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D005260:Female; D005838:Genotype; D006801:Humans; D007249:Inflammation / Q000097:blood; D016753:Interleukin-10 / Q000097:blood* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D020641:Polymorphism, Single Nucleotide; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012044:Regression Analysis; D018709:Statistics, Nonparametric; D013997:Time Factors
chemical_list: D015415:Biomarkers; D016753:Interleukin-10; D002097:C-Reactive Protein
references: Inflamm Res. 2005 May;54(5):187-93
references: 15953990
references: Med Hypotheses. 2005;65(1):103-6
references: 15893126
references: Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2667-72
references: 16239598
references: Am J Cardiol. 2006 Mar 1;97(5):640-5
references: 16490429
references: Ann N Y Acad Sci. 2007 Apr;1100:189-98
references: 17460178
references: Circulation. 2000 Apr 18;101(15):1767-72
references: 10769275
references: Annu Rev Immunol. 2001;19:683-765
references: 11244051
references: Circ Res. 2001 May 11;88(9):877-87
references: 11348996
references: Circulation. 2001 Aug 14;104(7):746-9
references: 11502695
references: JAMA. 2001 Nov 7;286(17):2107-13
references: 11694151
references: Am Heart J. 2002 Nov;144(5):811-7
references: 12422149
references: Genes Immun. 2002 Nov;3(7):407-13
references: 12424622
references: Transplantation. 2003 Mar 15;75(5):711-7
references: 12640314
references: Circulation. 2003 Apr 29;107(16):2109-14
references: 12668510
references: Coron Artery Dis. 2003 Sep;14(6):431-8
references: 12966263
references: Int J Cardiol. 2003 Dec;92(2-3):169-75
references: 14659849
references: J Am Coll Cardiol. 2003 Dec 3;42(11):1909-16
references: 14662251
references: Nephron. 1976;16(1):31-41
references: 1244564
references: J Immunol. 1991 Dec 1;147(11):3815-22
references: 1940369
references: J Exp Med. 1991 Nov 1;174(5):1209-20
references: 1940799
references: Circulation. 1995 Aug 1;92(3):657-71
references: 7634481
references: Eur J Immunogenet. 1997 Feb;24(1):1-8
references: 9043871
references: Circulation. 1997 Dec 16;96(12):4204-10
references: 9416883
references: Br J Haematol. 1998 Jul;102(2):597-604
references: 9695979
references: Clin Exp Immunol. 1998 Jul;113(1):59-64
references: 9697984
references: Lancet. 1999 Aug 28;354(9180):701-7
references: 10475180
references: Lancet. 1999 Aug 28;354(9180):708-15
references: 10475181
references: J Lipid Res. 2005 Feb;46(2):211-9
references: 15547296
references: Cytokine. 2005 Mar 7;29(5):215-28
references: 15760678
references: N Engl J Med. 2005 Apr 21;352(16):1685-95
references: 15843671
references: J Intern Med. 2005 Nov;258(5):411-9
references: 16238676